How Boards Can Use Empathy As A Key Differentiator In M&A Success
Covid has created an urgency to prioritize humanity and empathy in the M&A process—and the need for that humane diligence won’t disappear when we reach widespread immunity.
Covid has created an urgency to prioritize humanity and empathy in the M&A process—and the need for that humane diligence won’t disappear when we reach widespread immunity.
Proxy season is coming and no company is immune from activist campaigns. A look at what attracts an activist investor, common activist objectives and the board’s responsibilities and opportunities related to preparing for and responding to an activist.
More than 25 recent interviews revealed that nom/gov chairs are leading the conversations and actions around hot topics such as DE&I, ESG and board effectiveness and governance.
The move marks a significant escalation in the Biden administration’s emphasis on ESG issues, which it emphasized throughout the election.
Vaccines, consumer behavior and pent-up demand fuel optimism in America’s boardrooms.